Prestige Consumer Healthcare Inc. (PBH) stock
PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3024% below fair value
$50.62+2.40 (+4.98%)
Close on Nov 18, 2026Market cap $2.40BP/E 14.2Yield –
Prestige Consumer Healthcare r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Prestige Consumer Healthcare
Prestige Consumer Healthcare has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?